Glenna K. Mileson
Net Worth
Last updated:
What is Glenna K. Mileson net worth?
The estimated net worth of Ms. Glenna K. Mileson is at least $1,741,308 as of 28 Dec 2022. She owns shares worth $63,716 as insider, has earned $7,032 from insider trading and has received compensation worth at least $1,670,560 in Athira Pharma, Inc..
What is the salary of Glenna K. Mileson?
Ms. Glenna K. Mileson salary is $417,640 per year as Chief Financial Officer & Corporation Sec. in Athira Pharma, Inc..
How old is Glenna K. Mileson?
Ms. Glenna K. Mileson is 66 years old, born in 1959.
What stocks does Glenna K. Mileson currently own?
As insider, Ms. Glenna K. Mileson owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Athira Pharma, Inc. (ATHA) | Chief Financial Officer & Corporation Sec. | 159,930 | $0.4 | $63,716 |
What does Athira Pharma, Inc. do?
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Glenna K. Mileson insider trading
Athira Pharma, Inc.
Ms. Glenna K. Mileson has made only one insider trade between 2021-2022, according to the Form 4 filled with the SEC. She purchased 50,000 units of ATHA stock worth $142,250 on 28 Dec 2022.
As of 28 Dec 2022 she still owns at least 159,930 units of ATHA stock.
Athira Pharma key executives
Athira Pharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Hans Moebius (68) Chief Medical Officer
- Ms. Glenna K. Mileson (66) Chief Financial Officer & Corporation Sec.